To assess the efficacy of IV administered natalizumab, monthly for 1 year, in preventing relapses during the postpartum period.
IV - Research Studies occurring after FDA has approved a drug for marketing. These studies gather additional information about a drug's safety, efficacy, or optimal use.
University of Colorado Hospital
Protocol Number: 16-0156
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers